Abstract
Diabetes has become the fifth leading cause of death across developed markets,
and cases of the disease are forecast to grow by 7.1% across the globe by
2013. The market for innovative diabetes treatments will be driven by this
projected rise in prevalence, together with the substantial unmet need for
drugs that can effectively halt or reverse disease progression. Although
extended lifecycle management for existing antidiabetic therapies may offer
sales growth in the short term, the development of new drugs from novel
classes will become increasingly important in the future. However, the
potential introduction of stricter regulations for diabetes drug development
and recent setbacks for novel products have increased speculation about the
potential of innovative treatments. ' Innovations in the Management of
Diabetes: Next generation treatments and market dynamics' is a new report
published by Business Insights that analyzes the emerging drug classes, novel
drug delivery technologies and future growth drivers of the diabetes market.
This report explores the major trends and issues affecting the development of
novel products and assesses the future potential of leading innovations. The
major areas of unmet need in the market are identified and the currently
marketed portfolios and developmental compounds of key companies operating
within the sector are assessed. This report also examines recent concerns
about the safety profiles of marketed products and the possible implementation
of stricter FDA regulations. Explore the latest trends and innovations in
diabetes treatments, assess the currently marketed portfolios and pipelines of
leading players and identify future market opportunities with this report.
View Cart
